Updated on 18 September 2026
Key Expertise and Contribution Areas
EU project manager at INOC - Istituto Nazionale Oncologico Candiolo
Turin, Italy
About
(HORIZON-MISS-2027-02-CANCER-04)
INOC can support:
Patient-centred cancer care research Real-world evidence generation Patient-reported outcomes and quality-of-life studies Evaluation of healthcare pathways Equity and access analyses Assessment of value-based cancer care models Stakeholder engagement including patients and healthcare providers Virtual Human Twins and AI-Based Clinical Decision Support
(HORIZON-HLTH-2027-03-TOOL-04)
INOC is particularly interested in collaborations involving:
Multi-modal oncology datasets Clinical implementation of AI tools Validation of predictive models Digital twins for oncology screening, prevention and diagnosis AI-supported clinical decision-making Federated learning and trusted health data environments AGI and Next-Generation AI for Healthcare
(HORIZON-HLTH-2027-03-TOOL-08)
INOC seeks partnerships in: (HORIZON-MISS-2027-02-CANCER-04)
INOC can support:
Patient-centred cancer care research Real-world evidence generation Patient-reported outcomes and quality-of-life studies Evaluation of healthcare pathways Equity and access analyses Assessment of value-based cancer care models Stakeholder engagement including patients and healthcare providers Virtual Human Twins and AI-Based Clinical Decision Support
(HORIZON-HLTH-2027-03-TOOL-04)
INOC is particularly interested in collaborations involving:
Multi-modal oncology datasets Clinical implementation of AI tools Validation of predictive models Digital twins for oncology screening, prevention and diagnosis AI-supported clinical decision-making Federated learning and trusted health data environments AGI and Next-Generation AI for Healthcare
(HORIZON-HLTH-2027-03-TOOL-08)
INOC seeks partnerships in:
Advanced AI and foundation models for oncology Clinical reasoning systems Multi-agent healthcare AI environments Responsible and trustworthy AI Explainable AI in clinical settings Validation of AI solutions in real-world cancer care
Topic
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
Type
- Partner seeks Consortium/Coordinator
- Consortium/Coordinator seeks Partners
Similar opportunities
Project cooperation
Human-Centred Oversight for Trustworthy AI in Health and Cancer Care
- Partner seeks Consortium/Coordinator
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-08 Towards Artificial General Intelligence (AGI) for healthcare
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Bram Lievens
Research Valorisation Manager at IMEC-SMIT, Vrije Universiteit Brussel
Brussels, Belgium
Project cooperation
SIGORIA Expertise for Horizon Europe Calls: DISEASE-01, CANCER-02 & TOOL-04
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Sebastian Kawczyński
CEO at SIGORIA SECURITY SOLUTIONS
Łódź, Poland
Project cooperation
Fusing AI/ML with cheminformatics modelling into project concepts
- Partner seeks Consortium/Coordinator
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-08 Towards Artificial General Intelligence (AGI) for healthcare
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Evangelia-Mantelena Makri
Project Manager / Biomedical Scientist at Cloudpharm P.C
Athens, Greece